• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Immune Checkpoint Inhibitor Rechallenge in a Patient With Previous Fulminant Myocarditis.既往有暴发性心肌炎患者的免疫检查点抑制剂再激发治疗
Am J Cardiol. 2023 Jul 15;199:33-36. doi: 10.1016/j.amjcard.2023.04.037. Epub 2023 May 26.
2
Immune Checkpoint Inhibitor-Induced Myocarditis With Concurrent Myasthenia Gravis.免疫检查点抑制剂诱发的心肌炎合并重症肌无力
Can J Cardiol. 2023 Nov;39(11):1646-1648. doi: 10.1016/j.cjca.2023.06.007. Epub 2023 Jun 15.
3
The potential of auto-antigen-guided treatment of immune checkpoint inhibitor-mediated myocarditis.自身抗原导向治疗免疫检查点抑制剂介导心肌炎的潜力。
Med. 2023 Jan 13;4(1):13-14. doi: 10.1016/j.medj.2022.12.005.
4
An Autopsy Case of Late-onset Fulminant Myocarditis Induced by Nivolumab in Gastric Cancer.纳武利尤单抗致胃癌晚期暴发性心肌炎 1 例尸检报告
Intern Med. 2022 Oct 1;61(19):2867-2871. doi: 10.2169/internalmedicine.9161-21. Epub 2022 Mar 5.
5
Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis.阿巴西普用于治疗严重的免疫检查点抑制剂相关心肌炎
N Engl J Med. 2019 Jun 13;380(24):2377-2379. doi: 10.1056/NEJMc1901677.
6
[A case report of immune checkpoint inhibitor-induced myocarditis].
Zhonghua Xin Xue Guan Bing Za Zhi. 2022 Jul 24;50(7):710-712. doi: 10.3760/cma.j.cn112148-20210901-00763.
7
Immune checkpoint inhibitor-related myositis and myocarditis with multiple myositis-specific/-associated antibodies.免疫检查点抑制剂相关的肌炎和心肌炎伴多种肌炎特异性/相关抗体
J Neurol Sci. 2023 Jan 15;444:120528. doi: 10.1016/j.jns.2022.120528. Epub 2022 Dec 17.
8
Focal myocarditis associated with immune checkpoint inhibitor therapy.
Eur Heart J Cardiovasc Imaging. 2023 Nov 23;24(12):e308. doi: 10.1093/ehjci/jead228.
9
Survival After Fulminant Myocarditis Induced by Immune-Checkpoint Inhibitors.免疫检查点抑制剂诱发暴发性心肌炎后的生存情况
Ann Intern Med. 2017 Nov 7;167(9):683-684. doi: 10.7326/L17-0396. Epub 2017 Sep 5.
10
New biomarker-based strategy screens for myocarditis after immune checkpoint inhibitor treatment.
Cancer. 2023 May 1;129(9):1304. doi: 10.1002/cncr.34777.

引用本文的文献

1
Navigating Cardiotoxicity in Immune Checkpoint Inhibitors: From Diagnosis to Long-Term Management.免疫检查点抑制剂相关心脏毒性的应对：从诊断到长期管理
J Cardiovasc Dev Dis. 2025 Jul 16;12(7):270. doi: 10.3390/jcdd12070270.
2
Therapeutic agents for steroid-refractory immune checkpoint inhibitor-related myocarditis: a narrative review.类固醇难治性免疫检查点抑制剂相关心肌炎的治疗药物：一项叙述性综述
Cardiovasc Diagn Ther. 2024 Aug 31;14(4):679-697. doi: 10.21037/cdt-24-114. Epub 2024 Aug 12.
3
Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge.免疫检查点抑制剂相关心肌炎：诊断、治疗及再次激发的现状
J Clin Med. 2023 Dec 17;12(24):7737. doi: 10.3390/jcm12247737.

本文引用的文献

1
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.免疫治疗相关毒性管理，版本 1.2022，NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2022 Apr;20(4):387-405. doi: 10.6004/jnccn.2022.0020.
2
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events.癌症免疫治疗学会（SITC）免疫检查点抑制剂相关不良反应临床实践指南。
J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2021-002435.
3
Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis.免疫检查点抑制剂相关心肌炎患者的临床特征、病程、治疗和结局。
J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2021-002553.
4
Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer.癌症患者因出现 ≥2 级免疫相关不良反应而停止使用免疫检查点抑制剂后再次使用的安全性。
J Immunother Cancer. 2020 Dec;8(2). doi: 10.1136/jitc-2020-001622.
5
Rechallenge patients with immune checkpoint inhibitors following severe immune-related adverse events: review of the literature and suggested prophylactic strategy.免疫检查点抑制剂治疗后发生严重免疫相关不良事件的患者的再次挑战：文献复习及建议的预防策略。
J Immunother Cancer. 2020 Jun;8(1). doi: 10.1136/jitc-2020-000604.
6
Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer.癌症患者发生免疫相关不良反应后免疫检查点抑制剂的再次挑战
JAMA Oncol. 2020 Jun 1;6(6):865-871. doi: 10.1001/jamaoncol.2020.0726.
7
Case of pembrolizumab-induced myocarditis presenting as torsades de pointes with safe re-challenge.帕博利珠单抗诱发的心肌炎表现为尖端扭转型室速且成功再次激发的病例。
J Oncol Pharm Pract. 2020 Sep;26(6):1544-1548. doi: 10.1177/1078155220904152. Epub 2020 Feb 23.
8
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study.免疫检查点抑制剂相关的心血管毒性：一项观察性、回顾性、药物警戒研究。
Lancet Oncol. 2018 Dec;19(12):1579-1589. doi: 10.1016/S1470-2045(18)30608-9. Epub 2018 Nov 12.
9
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.免疫检查点抑制剂治疗患者的心肌炎。
J Am Coll Cardiol. 2018 Apr 24;71(16):1755-1764. doi: 10.1016/j.jacc.2018.02.037. Epub 2018 Mar 19.
10
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.免疫检查点抑制剂治疗患者免疫相关不良反应的管理：美国临床肿瘤学会临床实践指南。
J Clin Oncol. 2018 Jun 10;36(17):1714-1768. doi: 10.1200/JCO.2017.77.6385. Epub 2018 Feb 14.

Immune Checkpoint Inhibitor Rechallenge in a Patient With Previous Fulminant Myocarditis.

作者信息

Menachery Sherin M, Hang Yiwei, Pritchard Laura, Poklepovic Andrew, Bottinor Wendy

机构信息

Departments of Internal Medicine Virginia Commonwealth University Health System, Richmond, Virginia.

Virginia Commonwealth University School of Medicine, Richmond, Virginia.

出版信息

Am J Cardiol. 2023 Jul 15;199:33-36. doi: 10.1016/j.amjcard.2023.04.037. Epub 2023 May 26.

DOI:10.1016/j.amjcard.2023.04.037
PMID:37245247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10330624/
Abstract
摘要